Pellecome is setting the standard in Bio-identical Hormone Replacement Therapy (BHRT) by providing solutions to Healthcare Providers.
In mid-2018, Pellecome is launching the Re3™ Advanced Pellet Delivery System for Men and Women, which enables clinicians to insert hormone pellets easily and safely using patent pending technology.
Later in 2018, Pellecome will launch the Re3™ Advanced Pellet Formulations. Partnering with an established specialty pharmaceutical company, Pellecome has created pellet formulations that are designed to provide patients consistent and controlled hormone absorption. Pellecome Re3™ Advanced Pellet Formulations are manufactured in compliance with FDA requirements for potency, quality, and sterility according to regulations established for 503B Outsourcing Facilities to help ensure the safety and efficacy of hormone pellets. Our goal at Pellecome is to provide a safe and predictable method based on controlled-release technologies supported by clinical evidence.
We are committed to providing physicians with training that is focused on achieving the optimal insertion technique with a minimal risk profile. These courses are offered frequently and in several geographical locations for your convenience.
Pellecome LLC is headquartered in Randolph, New Jersey, with manufacturing sites in multiple locations.